Sign In
Buy OPRX
$4.95
-0.330 (-6.25%)
At Close: Jun 03, 2026
Doug Baker transitions to executive vice president of finance and accounting Doug Baker transitions to executive vice president of finance and accounting
OptimizeRx Survey Demonstrates Value of Digital Solutions in Addressing Unmet Patient and Provider Needs in Diabetes
08:00am, Wednesday, 29'th Sep 2021
Digital solutions provide new opportunities to support brand and HCP patient engagement challenges in survey of top U.S. endocrinologists Digital solutions provide new opportunities to support brand a
The Companies' combined point-of-care-engine creates an unmatched network of direct-to-physician digital interaction The Companies' combined point-of-care-engine creates an unmatched network of direct
OptimizeRx Corporation (OPRX) CEO William Febbo on Q2 2021 Results - Earnings Call Transcript
10:05pm, Wednesday, 04'th Aug 2021
OptimizeRx Corporation (OPRX) CEO William Febbo on Q2 2021 Results - Earnings Call Transcript
OptimizeRx: Q2 Earnings Insights
05:04pm, Wednesday, 04'th Aug 2021
Shares of OptimizeRx (NASDAQ:OPRX) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 400.00% year over year to $0.10, which beat t
OptimizeRx Sets Second Quarter Fiscal 2021 Conference Call for Wednesday, August 4 at 4:30 p.m. ET
08:00am, Tuesday, 27'th Jul 2021
ROCHESTER, Mich., July 27, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patie
2 Top Small-Cap Stocks to Buy in July
06:39am, Thursday, 08'th Jul 2021
OptimizeRx and Nano-X Imaging are two of my favorite small-caps right now. Here's why.
The 1 Stock I'd Buy Right Now
05:49am, Saturday, 03'rd Jul 2021
I'm confident that Schrodinger will be a 10-bagger over the next decade. And it might go up a lot more than that.
OptimizeRx Corp. (OPRX) Upgraded to Strong Buy: Here's Why
12:46pm, Thursday, 01'st Jul 2021
OptimizeRx Corp. (OPRX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
OptimizeRx to Present at RBC Capital Markets Global Virtual Healthcare Conference on May 19, 2021
08:00am, Tuesday, 11'th May 2021
ROCHESTER, Mich., May 11, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patien
OptimizeRx Corporation (OPRX) CEO William Febbo on Q1 2021 Results - Earnings Call Transcript
09:46am, Sunday, 09'th May 2021
OptimizeRx Corporation (OPRX) CEO William Febbo on Q1 2021 Results - Earnings Call Transcript
OptimizeRx Corp. (OPRX) Q1 Earnings and Revenues Beat Estimates
07:32pm, Thursday, 06'th May 2021
OptimizeRx Corp. (OPRX) delivered earnings and revenue surprises of 200.00% and 8.79%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
OptimizeRx Sets First Quarter 2021 Conference Call for Thursday, May 6, 2021 at 4:30 p.m. ET
08:00am, Wednesday, 28'th Apr 2021
ROCHESTER, Mich., April 28, 2021 (GLOBE NEWSWIRE) -- OptimizeRx Corporation (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, will hol
OptimizeRx Expands Omni-channel Platform Reach at Point-Of-Care
07:51am, Tuesday, 27'th Apr 2021
Several New Partnerships Expand Reach to Over 50% of Oncologists in the U.S. and Unlock Novel Touchpoints for Life Sciences to Engage Physicians Several New Partnerships Expand Reach to Over 50% of On
OptimizeRx Stock Is Just Getting Started
05:57am, Tuesday, 20'th Apr 2021
OptimizeRx is an industry leader in providing digital health solutions for pharmaceutical companies, healthcare providers, and patients.
